IFNAR1 and neoplasm: In terms of therapeutic tumour control, VSV-GP-Luc was found to be as effective as VSV-GP on LLC1-IFNAR1−/− tumours leading to rapid tumour remission in syngeneic C57BL/6J as well as NMRI-nu mouse model (Fig. 4c, f).